Literature DB >> 16328515

A 3'-UTR polymorphism in the oxidized LDL receptor 1 gene increases Abeta40 load as cerebral amyloid angiopathy in Alzheimer's disease.

Jing Shi1, Jinzhou Tian, Antonia Pritchard, Corinne Lendon, Jean-Charles Lambert, Takeshi Iwatsubo, David M A Mann.   

Abstract

It is presently unclear whether polymorphic variations in the oxidized low-density lipoprotein receptor 1 (OLR1), or low-density lipoprotein receptor-related protein 1 (LRP1), genes act as risk factors for Alzheimer's disease (AD). In the present study, we have investigated the extent of amyloid beta protein (Abeta) deposition as cerebral amyloid angiopathy (CAA) or senile plaques (SP) in relationship to OLR1 +1071 and +1073 polymorphisms and LRP1 C766T polymorphism in patients with AD There was an increased Abeta40 load as CAA, but not as SP, in frontal cortex of AD patients carrying OLR1+1073 CC genotype, compared to those with CT, TT or CT+TT genotypes, but only in those individuals without apolipoprotein (APOE) epsilon4 allele. No differences in total Abeta or Abeta42 load as CAA or SP between OLR1+1073 genotypes was seen, nor were there any differences between OLR1+1071 and LRP1 genotypes for any measure of Abeta. Present data suggests that homozygosity for the C allele for OLR1+1073 polymorphism, selectively in individuals without APOE epsilon4 allele, may impair clearance of Abeta, and particularly Abeta40, from the brain across the blood-brain barrier, leading to its 'diversion' into perivascular drainage channels, thereby increasing the severity of CAA in such persons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16328515     DOI: 10.1007/s00401-005-1108-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

Review 1.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

Review 2.  Is the LDL receptor involved in cortical amyloid protein clearance?

Authors:  Yasir Abdulkarim; Zeyad Hameed
Journal:  Neurochem Res       Date:  2006-07-14       Impact factor: 3.996

3.  Sequential Therapy Based on Evolvement of Patterns: A New Model for Treatment of Alzheimer's Disease.

Authors:  Jin-Zhou Tian; Jing Shi; Jing-Nian Ni; Ming-Qing Wei; Xue-Kai Zhang; Ke-Ji Chen; Yong-Yan Wang
Journal:  Chin J Integr Med       Date:  2019-05-07       Impact factor: 1.978

4.  Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease.

Authors:  Rukhsana Sultana; William A Banks; D Allan Butterfield
Journal:  J Neurosci Res       Date:  2010-02-15       Impact factor: 4.164

Review 5.  Noncoding RNAs in neurodegeneration.

Authors:  Evgenia Salta; Bart De Strooper
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

6.  Microglial scavenger receptors and their roles in the pathogenesis of Alzheimer's disease.

Authors:  Kim Wilkinson; Joseph El Khoury
Journal:  Int J Alzheimers Dis       Date:  2012-05-15

7.  Differentially expressed genes in Alzheimer's disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1.

Authors:  Qingqin S Li; Louis De Muynck
Journal:  Brain Behav Immun Health       Date:  2021-02-24

8.  Association of lectin-like oxidized low density lipoprotein receptor 1 (OLR1) polymorphisms with late-onset Alzheimer disease in Han Chinese.

Authors:  Zuo-Teng Wang; Xiao-Ling Zhong; Meng-Shan Tan; Hui-Fu Wang; Chen-Chen Tan; Wei Zhang; Zhan-Jie Zheng; Ling-Li Kong; Lan Tan; Li Sun
Journal:  Ann Transl Med       Date:  2018-05

Review 9.  Role of scavenger receptors in glia-mediated neuroinflammatory response associated with Alzheimer's disease.

Authors:  Francisca Cornejo; Rommy von Bernhardi
Journal:  Mediators Inflamm       Date:  2013-05-07       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.